Sabby Management, LLC Vascular Biogenics Ltd. Transaction History

Sabby Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$0.96 - $1.57 $77,083 - $126,063	-80,295 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.1 - $1.32 $43,324 - $51,989	-39,386 Reduced 32.91%	80,295 $96,000
Q3 2019 Nov 15, 2019	SELL	$1.11 - $1.42 $132,652 - $169,699	-119,507 Reduced 49.96%	119,681 $162,000
Q2 2019 Aug 14, 2019	SELL	$1.16 - $1.53 $102,446 - $135,123	-88,316 Reduced 26.97%	239,188 $311,000
Q1 2019 May 15, 2019	SELL	$0.94 - $1.75 $1.92 Million - $3.58 Million	-2,045,699 Reduced 86.2%	327,504 $498,000
Q4 2018 Feb 14, 2019	BUY	$0.6 - $1.72 $148,479 - $425,639	247,465 Added 11.64%	2,373,203 $2.3 Million
Q3 2018 Nov 14, 2018	BUY	$1.55 - $2.17 $417,831 - $584,964	269,569 Added 14.52%	2,125,738 $3.45 Million
Q2 2018 Aug 14, 2018	BUY	$2.05 - $3.0 $3.81 Million - $5.57 Million	1,856,169 New	1,856,169 $4.08 Million

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.